Impact of bronchodilator therapy on exercise tolerance in COPD. (Q33831434)

29 July 2017

1 reference

title

Impact of bronchodilator therapy on exercise tolerance in COPD. (English)

1 reference

29 July 2017

B Aguilaniu

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

7 April 2010

1 reference

International Journal of Chronic Obstructive Pulmonary Disease

29 July 2017

published in

1 reference

29 July 2017

volume

5

1 reference

29 July 2017

page(s)

57-71

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

29 July 2017

copyright license

start time

1 March 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Outcome Measures in Cardiopulmonary Physical Therapy: Focus on the Glittre ADL-Test for People with Chronic Obstructive Pulmonary Disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Predictors of mortality in patients with emphysema and severe airflow obstruction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Addition of salmeterol to existing treatment in patients with COPD: a 12 month study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Role of bronchodilators in chronic obstructive pulmonary disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Chronic obstructive pulmonary disease: epidemiology, pathogenesis, disease course, and prognosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Burden and clinical features of chronic obstructive pulmonary disease (COPD).

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

The impact of tobacco on lung health in China

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

ATS/ACCP Statement on cardiopulmonary exercise testing

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

An evaluation of salmeterol in the treatment of chronic obstructive pulmonary diseases.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

A Systematic Review of the Effects of Bronchodilators on Exercise Capacity in Patients With COPD

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Ventilatory limitations in chronic obstructive pulmonary disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Recommendations for the management of COPD.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Functional performance in people with chronic obstructive pulmonary disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Effect of oral salbutamol and slow-release aminophylline on exercise tolerance in chronic bronchitis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Dose-response study of inhaled salbutamol powder in chronic airflow obstruction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Breathlessness and exercise tolerance in chronic airflow obstruction: 2-hourly versus 4-hourly salbutamol by inhalation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Development of a shuttle walking test of disability in patients with chronic airways obstruction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Clinical relevance of constant power exercise duration changes in COPD.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and acti

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Exercise in severe COPD: is walking different from stair-climbing?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Endurance shuttle walking test: responsiveness to salmeterol in COPD.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Single dose of tiotropium improves the 6-minute walk distance in chronic obstructive pulmonary disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

A field test of functional status as performance of activities of daily living in COPD patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes *

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Effects of formoterol (Oxis Turbuhaler) and ipratropium on exercise capacity in patients with COPD.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Improvements in exercise capacity and dyspnoea by inhaled anticholinergic drug in elderly patients with chronic obstructive pulmonary disease.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Salbutamol and ipratropium in partially reversible airway obstruction

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2865026

Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease

29 October 2018

1 reference

12 December 2020

The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests

1 reference

12 December 2020

The cumulative effect of long-acting bronchodilators, exercise, and inspiratory muscle training on the perception of dyspnea in patients with advanced COPD

1 reference

12 December 2020

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

1 reference

12 December 2020

Limitation to muscular activity in chronic obstructive pulmonary disease

1 reference

12 December 2020

Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease

1 reference

12 December 2020

Development of an unsupported arm exercise test in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients?

1 reference

12 December 2020

Effects of formoterol on exercise tolerance in severely disabled patients with COPD

1 reference

12 December 2020

Effect of controlled-release salbutamol in predominantly non-reversible chronic airflow obstruction

1 reference

12 December 2020

Minimum clinically important improvement for the incremental shuttle walking test

1 reference

12 December 2020

Interpretation of treatment changes in 6-minute walk distance in patients with COPD

1 reference

12 December 2020

Relationship between pulmonary function and physical activity in daily life in patients with COPD

1 reference

12 December 2020

Perceptual and physiologic responses during treadmill and cycle exercise in patients with COPD

1 reference

12 December 2020

Measurement of Functional Activity in Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

[Dyspnea and handicap in chronic obstructive pulmonary disease: interaction of their mechanisms]

1 reference

12 December 2020

Is an Anticholinergic Agent Superior to a β2-Agonist in Improving Dyspnea and Exercise Limitation in COPD?

1 reference

12 December 2020

Oxitropium bromide improves exercise performance in patients with COPD

1 reference

12 December 2020

Effects of inhaled anticholinergic drug on dyspnea and gas exchange during exercise in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Long-term effects of inhaled anticholinergic drug on lung function, dyspnea, and exercise capacity in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients

1 reference

12 December 2020

Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease

1 reference

12 December 2020

Identifiers

DOI

10.2147/COPD.S7404

1 reference

29 July 2017

1 reference

29 July 2017

1 reference